Overview
This page compares Injective and ULTIMA with live PEPS metrics. Rankings (#99 vs #156) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | INJ | ULTIMA |
|---|---|---|
| Price | $5.08 | $1,874.22 |
| Market Cap | $490.41M | $209.91M |
| FDV | — | — |
| Volume 24h | $2.27M | $2.55M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 156.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | ULTIMA |
|---|---|---|
| 1H | — | — |
| 24H | +4.65% | +2.60% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | ULTIMA |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 63.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Use the indicator table as a checklist: if momentum and trend align on one asset while the other diverges, relative-value setups become more interesting — still without certainty.
Fundamentals
| Metric | INJ | ULTIMA |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
ULTIMA
Pros and cons
Pros of Injective
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
- Injective typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
Cons of Injective
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
Pros of ULTIMA
- Diversifying versus Injective with ULTIMA can change portfolio factor exposure.
- Active volume bursts on ULTIMA sometimes precede sharper tactical moves.
- PEPS tracking for ULTIMA still includes AI score and level context for monitoring.
- Narrative optionality around ULTIMA can reprice quickly when catalysts appear.
Cons of ULTIMA
- Weaker market-cap standing may leave ULTIMA more exposed to liquidity droughts.
- Relative underperformance versus Injective can persist through entire market regimes.
- Trend failures on ULTIMA often travel faster than on more established assets.
Which looks stronger right now?
Statistically, higher market cap (Injective) often correlates with deeper books, while hotter 24h prints (Injective) can fade. Position sizing should reflect that uncertainty.
AI summary
In about three hundred words of context: Injective (INJ) trades near $5.08 with a +4.65% day move, while ULTIMA (ULTIMA) is around $1,874.22 (+2.60%). Volume leadership currently sits with ULTIMA, and market-cap leadership with Injective. Technical trend labels read neutral vs bearish, with RSI near 49.29/49.02. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, Injective or ULTIMA?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or ULTIMA?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and ULTIMA.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. ULTIMA currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.